Increased DHT in androgen alopecia to protect from prostate cancer
Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer.
Authors
Bhargava S.
Journal
Med Hypotheses. 2014 Jan 26. pii: S0306-9877(14)00027-9. doi: 10.1016/j.mehy.2014.01.016. [Epub ahead of print]
Affiliation
Abstract
Androgenic alopecia, a condition characterized by increased levels of DHT could have been selected for due to the benefits that prostaglandin D2 (PGD2) has on the prostate. A DHT metabolite can increase the transcription of prostaglandin D2 synthase through estrogen receptor beta. The increase of PGD2 can decrease the risk of prostate cancer and proliferation of prostate cancer cells. Therefore, the mechanisms behind male pattern baldness may also curtail the advancement of prostate cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.
PMID 24548754 [PubMed - as supplied by publisher]
Full text: Elsevier Science
Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer.
Authors
Bhargava S.
Journal
Med Hypotheses. 2014 Jan 26. pii: S0306-9877(14)00027-9. doi: 10.1016/j.mehy.2014.01.016. [Epub ahead of print]
Affiliation
Abstract
Androgenic alopecia, a condition characterized by increased levels of DHT could have been selected for due to the benefits that prostaglandin D2 (PGD2) has on the prostate. A DHT metabolite can increase the transcription of prostaglandin D2 synthase through estrogen receptor beta. The increase of PGD2 can decrease the risk of prostate cancer and proliferation of prostate cancer cells. Therefore, the mechanisms behind male pattern baldness may also curtail the advancement of prostate cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.
PMID 24548754 [PubMed - as supplied by publisher]
Full text: Elsevier Science